Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03681678 · ClinicalTrials.gov registry record

Laser Therapy for Treatment of Urogenital Symptoms in Women

A clinical trial, sponsored by Corewell Health East.

Completed
Registry status
100
Enrollment target

NCT03681678 is a clinical trial that has completed, run by Corewell Health East. The registered enrollment target is 100 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03681678 has completed, sponsored by Corewell Health East.

COMPLETED
Registry status
100 participants
Enrollment target

Study Summary

This is a prospective observational study of women undergoing vaginal treatment with the fractional carbon dioxide (fCO2) laser for various urogenital symptoms.

Interventions

  • DEVICE fCO2 Laser Therapy Group

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2018-10-08
Est. Completion 2025-06-10

Sponsor

Corewell Health East

106 total trials

What the Registry Record Tells You About NCT03681678

The ClinicalTrials.gov registry entry for NCT03681678 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Corewell Health East, which has 106 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which fCO2 Laser Therapy Group is the first listed.

NCT03681678 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03681678 about?

NCT03681678 is a clinical study titled "Laser Therapy for Treatment of Urogenital Symptoms in Women". This is a prospective observational study of women undergoing vaginal treatment with the fractional carbon dioxide (fCO2) laser for various urogenital symptoms.

What is the current status of trial NCT03681678?

This trial is currently completed. The enrollment target is 100 participants. The study started on 2018-10-08. Estimated completion is 2025-06-10.

What interventions are being tested in trial NCT03681678?

The interventions under investigation include: fCO2 Laser Therapy Group (DEVICE).

Who is sponsoring clinical trial NCT03681678?

This trial is sponsored by Corewell Health East, which has 106 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.